CN105943644B - A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain - Google Patents
A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain Download PDFInfo
- Publication number
- CN105943644B CN105943644B CN201610494727.9A CN201610494727A CN105943644B CN 105943644 B CN105943644 B CN 105943644B CN 201610494727 A CN201610494727 A CN 201610494727A CN 105943644 B CN105943644 B CN 105943644B
- Authority
- CN
- China
- Prior art keywords
- parts
- moxibustion
- chinese medicine
- salt
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
Abstract
The present invention relates to a kind of Chinese medicine moxibustion compositions for lumbar muscle strain, are made of following bulk drugs: 40-60 parts of caulis piperis futokadsurae, 30-50 parts of the root of Chinese clematis, 35-55 parts of rhizoma cibotii, 40-60 parts of psoralea corylifolia, 50-70 parts of lopseed, 30-50 parts of lycopodium calvatum, 25-45 parts of Rhizoma Chuanxiong, 50-70 parts of ramulus mori, 40-60 parts of radix achyranthis bidentatae, 1-3 parts of borneol.The present invention is ingenious to be incorporated every the salt moxibustion and moxibustion box moxibustion the advantages of, had not only been remained two kinds of respective advantages of moxibustion therapy, but also joined prescription, and had been collected the one that acts on every salt moxibustion, herbs-partition moxibustion and moxibustion box moxibustion, three-in-one performance curative effect.Meanwhile avoid every salt moxibustion and the moxibustion of moxibustion box there are the drawbacks of.Present invention materials are easy, are easy to learn and use, curative effect is reliable, it has been that numerous patients release pain, medicine salt moxibustion not only increases the osmosis that moxa-moxibustion is conducted slowly, played the therapeutic effect of drug, moxibustion time is extended, and effectively prevents scalding the generation steeped during moxa-moxibustion.
Description
Technical field
The present invention relates to medical and health care technical fields, specifically, being a kind of Chinese medicine moxibustion group for lumbar muscle strain
Close object and its preparation method and application.
Background technique
" moxa-moxibustion " refers to based on moxa on body surface point or affected part temperature is pressed, fire-cureed to prevent and cure diseases and health body-building
A kind of external treatment with Chinese medicine method is the important branch of traditional Chinese medicine.Moxibustion therapy has warming meridian, dispelling cold and removing dampness, activating microcirculation and removing stasis medicinal, temperature
The effect of yang-tonifying gas and health care.Thousands of years of clinical practice proves the remarkable result of moxa-moxibustion again and again.Nowadays, moxibustion therapy is still wide
It is general to be applied to clinic, slight illness also is being released for many patients, is being a kind of very outstanding external treatment of traditional Chinese medicine.
There are many classification of moxibustion therapy, and in moxa-moxibustion, sandwiched moxibustion and moxa-moxibustion box moxibustion are at present using very universal moxibustion method.
Sandwiched moxibustion head sees Ge Hong handbook of Prescription for Emergency, is divided into every ginger moxibustion, every monkshood cake moxibustion, garlic moxibustion, every salt moxibustion etc..It is every salt moxibustion
The salt of finger clean dry fills and leads up omphalos, the method for above setting big moxa cone moxibustion, has recuperating depleted yang, warming spleen and stomach for dispelling cold, under warm
Burnt effect, is for general on the moxibustion of navel position.Moxa-moxibustion box moxibustion is that moxa stick one end that 4-5 is cut 5cm or so length is lighted, point
It is not endways to put moxibustion box into, it is supplied oxygen by adjusting box cover and the aperture on box body both sides to improve, to control the moxibustion temperature of moxibustion box；
Moxa-moxibustion box moxibustion can be widely applied to the flat parts such as shoulder back waist abdomen, especially suitable for sympotoms caused by cold factors, the chronic diseases marked by deficiency of vital energy, stasis of blood disease.
Though it is good to act on every salt moxibustion, it is limited only to navel position, and moxibustion, to coda, salt, which easily bursts, scalds patient, food
Salt is filled into navel, and the component of general patient salt amount and moxa is difficult to hold, and such as felt boiling hot, and can not often handle, cause navel
Scald, disease do not obtain medical treatment, lose confidence to every salt moxibustion even moxa-moxibustion instead；The moxibustion of moxibustion box operates very square in contrast
Just, also relatively safer, but there is also moxibustion amounts to be difficult to the problem of holding, if moxibustion amount is excessive, the patient feels, which are burnt, scalds, and needs to lift
High moxibustion box or place mat gauze are next heat-insulated, and it is uneven often to will cause moxibustion heat, to influence therapeutic effect, scald are also easily caused to scald
Bubble.
Chinese patent 2009102314905 discloses a kind of skin surface infiltration Chinese medicinal preparation of acupuncture, including following
Component: folium artemisiae argyi, rhizoma corydalis, safflower, Radix Notoginseng, Rhizoma Chuanxiong, Caulis Spatholobi, borneol, Radix Angelicae Sinensis, ginger and rhizoma cyperi；When treatment face, headache are all
Asarum, Rhizoma Et Radix Notopterygii, the fruit of glossy privet, cassia seed and chrysanthemum is added in disease in the Chinese materia medica preparation component；Treat all disease Shi Jiamai of thorax abdomen
Men Dong, hairyvein agrimony, Chinese gall, Rhizoma Atractylodis Macrocephalae, rhizoma atractylodis and paniculate swallowwort；Add Radix Paeoniae Alba, motherwort, Chinese trumpet creeper, olibanum when the treatment all disease of gynaecology
And myrrh；Add Radix Salviae Miltiorrhizae, lopseed, lycopodium calvatum, the root of Chinese clematis, caulis trachelospermi, pheretima and the rhizome of davallia when all disease in treatment four limbs, joint；It should
Chinese materia medica preparation energy activating microcirculation and removing stasis medicinal, blood-enrich, and it is economical and practical, production method is simple, can obtain good economic benefits.It is Chinese special
Benefit 2007100848311 discloses a kind of moxibustion medicine for the treatment of pain of lumbus, leg, neck and shoulder, what which was made of following component, anxious
Temper, Radix Aconiti Kusnezoffii, arisacma consanguineum schott, dried pinellia, asarum, Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani), Chinese prickly ash, paniculate swallowwort, the root of Dahurain angelica, Chinese gall, enters ground at Radix Aconiti
Each equal portions of Taurus, Radix Angelicae Sinensis, Rhizoma Chuanxiong, peach kernel, safflower, the root of Chinese clematis, Radix Paeoniae Alba, gentianae macrophyllae, rhizoma cyperi, tripterygium wilfordii, in addition stating medicine gross weight
10% Mentholum, 10% borneol, 0.5% SEMEN SINAPIS ALBAE crush as 200 mesh fine powders, package, pharmaceutical composition treatment neck shoulder
Lumbago and scelalgia, it is significant in efficacy, and the course for the treatment of is shorter, quick.The prior art mainly passes through production Chinese materia medica preparation or medicinal powder package, or single
It is pure every salt moxibustion or moxibustion box moxibustion；And by being difficult to hold moxibustion amount every salt moxibustion or moxibustion box moxibustion, moxibustion effect is limited.Therefore it is directed to the prior art
The shortcomings that, it is necessary to it researches and develops a kind of collection and every salt moxibustion, herbs-partition moxibustion and moxibustion box moxibustion acts on the integrated moxibustion of medicine salt and Chinese medicine composition,
And about the technical solution, it yet there are no report.
Summary of the invention
" moxibustion of medicine salt " is a kind of compound moxibustion therapy moxa-moxibustion, green salt and Chinese medicine three's perfect combination.Belong to head of the invention
Wound application.Green salt, taste is salty, enters kidney, there is the function of diathermanous kidney tonifying, dispelling cold and dehumidification.Chinese medicine moxibustion composition of the invention acts on waist
The governor vessel and two sides bladder meridian in sacrum portion, take the big cave of the health cares such as shen shu, the gate of vitality, Yaoyangkuan(Du 3), have element culturing fixed folder, kidney tonifying marrow facilitating, relax
The active effect of muscle.Governor vessel leads to spinal cord, and spinal nerve distribution all has with internal each internal organs and is closely connected, back Yu of governor vessel both sides
Cave is also related to the vital organs of the human body, can improve whole body internal organs function by conditioning governor vessel and bladder meridian.Suitable for back muscular strain,
Meridian qi and blood blocks obstructed and whole body and integrally improves.
The purpose of the present invention is aiming at the shortcomings in the prior art, provide a kind of Chinese medicine composition for Chinese medicine moxibustion.
Another purpose of the invention is to provide a kind of Chinese medicine medicine salt for medicine salt moxibustion.
Another purpose of the invention is to provide Chinese medicine composition as described above, Chinese medicine medicine salt and treats psoas muscle in preparation
Strain, dysmenorrhea, irregular menstruation, pelvic inflammatory disease drug in application.
To achieve the above object, the technical solution adopted by the present invention is that:
A kind of Chinese medicine composition for Chinese medicine moxibustion, the Chinese medicine composition are made of the bulk pharmaceutical chemicals of following parts by weight:
40-60 parts of caulis piperis futokadsurae, 30-50 parts of the root of Chinese clematis, 35-55 parts of rhizoma cibotii, 40-60 parts of psoralea corylifolia, 50-70 parts of lopseed, lycopodium calvatum 30-
50 parts, 25-45 parts of Rhizoma Chuanxiong, 50-70 parts of ramulus mori, 40-60 parts of radix achyranthis bidentatae, 1-3 parts of borneol.
Preferably, the Chinese medicine composition is made of the bulk pharmaceutical chemicals of following parts by weight: 45-55 parts of caulis piperis futokadsurae, the root of Chinese clematis
35-45 parts, 40-50 parts of rhizoma cibotii, 45-55 parts of psoralea corylifolia, 55-65 parts of lopseed, 35-45 parts of lycopodium calvatum, 30-40 parts of Rhizoma Chuanxiong, mulberry
Branch 55-65 parts, 45-55 parts of radix achyranthis bidentatae, 1-2 parts of borneol.
Preferably, the Chinese medicine composition is made of the bulk pharmaceutical chemicals of following parts by weight: 50 parts of caulis piperis futokadsurae, 40 parts of the root of Chinese clematis,
45 parts of rhizoma cibotii, 50 parts of psoralea corylifolia, 60 parts of lopseed, 40 parts of lycopodium calvatum, 35 parts of Rhizoma Chuanxiong, 60 parts of ramulus mori, 50 parts of radix achyranthis bidentatae, 2 parts of borneol.
To realize above-mentioned second purpose, the technical solution adopted by the present invention is that:
A kind of Chinese medicine medicine salt for medicine salt moxibustion, the Chinese medicine medicine salt include in sea salt and any parts by weight as above
Drug composition.
Preferably, the parts by weight of the sea salt are 700-900 parts.
To realize above-mentioned third purpose, the technical solution adopted by the present invention is that:
As above any Chinese medicine composition, Chinese medicine medicine salt treat lumbar muscle strain, dysmenorrhea, irregular menstruation, basin in preparation
Application in the drug of chamber inflammation.
The drug the preparation method is as follows:
(1) raw material is weighed according to the proportion；
(2) Chinese medicine composition is crushed, is sieved with 100 mesh sieve, obtain medicinal powder；
(3) sea salt mild fire frying is taken, medicinal powder prepared by step 2, together frying is added in when light yellow complexion.
The invention has the advantages that:
1, the present invention has played moxa-moxibustion and the effect of Chinese medicine double treatment, substantially increases curative effect.
2, the present invention is easy to use, easily operated, can use in the family, be not limited to doctor and medical space, simultaneously
Price is far below General Clinical diagnosis and treatment price, is easy to universal.
3, the present invention is ingenious incorporates every the salt moxibustion and moxibustion box moxibustion the advantages of, has not only remained two kinds of respective advantages of moxibustion therapy, but also
It joined prescription, collect the one that acts on every salt moxibustion, herbs-partition moxibustion and moxibustion box moxibustion, three-in-one performance curative effect；Meanwhile avoid every
Salt moxibustion and the moxibustion of moxibustion box there are the drawbacks of.
4, medicine salt moxibustion of the invention is drawn materials easy, is easy to learn and use, and curative effect is reliable, releases pain, medicine salt for numerous patients
Moxibustion not only increases the osmosis that moxa-moxibustion is conducted slowly, has played the therapeutic effect of drug, has extended moxibustion time, Er Qieyou
Effect scalds the generation steeped during avoiding moxa-moxibustion.
5, Chinese medicine composition of the invention is for lumbar muscle strain, dysmenorrhea, irregular menstruation, the significant effect of pelvic inflammatory disease.
Detailed description of the invention
Attached drawing 1 is the pictorial diagram of Chinese medicine moxibustion composition of the present invention.
Specific embodiment
The invention will be further elucidated with reference to specific embodiments.It should be understood that these embodiments are merely to illustrate this hair
It is bright rather than limit the scope of the invention.In addition, it should also be understood that, after having read the content of the invention recorded, art technology
Personnel can make various changes or modifications the present invention, and such equivalent forms equally fall within the application the appended claims and limited
Fixed range.
Embodiment 1 is used for the Chinese medicine composition (one) of Chinese medicine moxibustion
50 parts of caulis piperis futokadsurae, 40 parts of the root of Chinese clematis, 45 parts of rhizoma cibotii, 50 parts of psoralea corylifolia, 60 parts of lopseed, 40 parts of lycopodium calvatum, Rhizoma Chuanxiong
35 parts, 60 parts of ramulus mori, 50 parts of radix achyranthis bidentatae, 2 parts of borneol.
Embodiment 2 is used for the Chinese medicine composition (two) of Chinese medicine moxibustion
40 parts of caulis piperis futokadsurae, 30 parts of the root of Chinese clematis, 35 parts of rhizoma cibotii, 40 parts of psoralea corylifolia, 50 parts of lopseed, 30 parts of lycopodium calvatum, Rhizoma Chuanxiong
25 parts, 50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 3 is used for the Chinese medicine composition (three) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 30 parts of the root of Chinese clematis, 35 parts of rhizoma cibotii, 40 parts of psoralea corylifolia, 50 parts of lopseed, 30 parts of lycopodium calvatum, Rhizoma Chuanxiong
25 parts, 50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 4 is used for the Chinese medicine composition (four) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 35 parts of rhizoma cibotii, 40 parts of psoralea corylifolia, 50 parts of lopseed, 30 parts of lycopodium calvatum, Rhizoma Chuanxiong
25 parts, 50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 5 is used for the Chinese medicine composition (five) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 40 parts of psoralea corylifolia, 50 parts of lopseed, 30 parts of lycopodium calvatum, Rhizoma Chuanxiong
25 parts, 50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 6 is used for the Chinese medicine composition (six) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 60 parts of psoralea corylifolia, 50 parts of lopseed, 30 parts of lycopodium calvatum, Rhizoma Chuanxiong
25 parts, 50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 7 is used for the Chinese medicine composition (seven) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 60 parts of psoralea corylifolia, 70 parts of lopseed, 30 parts of lycopodium calvatum, Rhizoma Chuanxiong
25 parts, 50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 8 is used for the Chinese medicine composition (eight) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 60 parts of psoralea corylifolia, 70 parts of lopseed, 50 parts of lycopodium calvatum, Rhizoma Chuanxiong
25 parts, 50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 9 is used for the Chinese medicine composition (nine) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 60 parts of psoralea corylifolia, 70 parts of lopseed, 50 parts of lycopodium calvatum, Rhizoma Chuanxiong
45 parts, 50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 10 is used for the Chinese medicine composition (ten) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 60 parts of psoralea corylifolia, 70 parts of lopseed, 50 parts of lycopodium calvatum, Rhizoma Chuanxiong
45 parts, 70 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 11 is used for the Chinese medicine composition (11) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 60 parts of psoralea corylifolia, 70 parts of lopseed, 50 parts of lycopodium calvatum, Rhizoma Chuanxiong
45 parts, 70 parts of ramulus mori, 60 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 12 is used for the Chinese medicine composition (12) of Chinese medicine moxibustion
60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 60 parts of psoralea corylifolia, 70 parts of lopseed, 50 parts of lycopodium calvatum, Rhizoma Chuanxiong
45 parts, 70 parts of ramulus mori, 60 parts of radix achyranthis bidentatae, 3 parts of borneol.
Embodiment 13 is used for the Chinese medicine composition (13) of Chinese medicine moxibustion
55 parts of caulis piperis futokadsurae, 45 parts of the root of Chinese clematis, 50 parts of rhizoma cibotii, 55 parts of psoralea corylifolia, 65 parts of lopseed, 45 parts of lycopodium calvatum, Rhizoma Chuanxiong
40 parts, 65 parts of ramulus mori, 55 parts of radix achyranthis bidentatae, 2 parts of borneol.
Embodiment 14 is used for the Chinese medicine composition (14) of Chinese medicine moxibustion
45 parts of caulis piperis futokadsurae, 35 parts of the root of Chinese clematis, 40 parts of rhizoma cibotii, 45 parts of psoralea corylifolia, 55 parts of lopseed, 35 parts of lycopodium calvatum, Rhizoma Chuanxiong
30 parts, 55 parts of ramulus mori, 45 parts of radix achyranthis bidentatae, 1 part of borneol.
Embodiment 15 is used for the Chinese medicine composition (15) of Chinese medicine moxibustion
45 parts of caulis piperis futokadsurae, 35 parts of the root of Chinese clematis, 40 parts of rhizoma cibotii, 45 parts of psoralea corylifolia, 55 parts of lopseed, 45 parts of lycopodium calvatum, Rhizoma Chuanxiong
40 parts, 65 parts of ramulus mori, 55 parts of radix achyranthis bidentatae, 2 parts of borneol.
Embodiment 16 is used for the Chinese medicine composition (16) of Chinese medicine moxibustion
45 parts of Radix Angelicae Sinensis, 40 parts of safflower, 50 parts of Radix Salviae Miltiorrhizae, 25 parts of radix aucklandiae, 40 parts of rhizoma cyperi, 80 parts of motherwort, 35 parts of Rhizoma Chuanxiong, borneol
2。
Embodiment 17 is used for the Chinese medicine composition (17) of Chinese medicine moxibustion
35 parts of Radix Angelicae Sinensis, 30 parts of safflower, 40 parts of Radix Salviae Miltiorrhizae, 15 parts of radix aucklandiae, 30 parts of rhizoma cyperi, 70 parts of motherwort, 25 parts of Rhizoma Chuanxiong, borneol
1。
Embodiment 18 is used for the Chinese medicine composition (18) of Chinese medicine moxibustion
55 parts of Radix Angelicae Sinensis, 30 parts of safflower, 40 parts of Radix Salviae Miltiorrhizae, 15 parts of radix aucklandiae, 30 parts of rhizoma cyperi, 70 parts of motherwort, 25 parts of Rhizoma Chuanxiong, borneol
1。
Embodiment 19 is used for the Chinese medicine composition (19) of Chinese medicine moxibustion
55 parts of Radix Angelicae Sinensis, 50 parts of safflower, 40 parts of Radix Salviae Miltiorrhizae, 15 parts of radix aucklandiae, 30 parts of rhizoma cyperi, 70 parts of motherwort, 25 parts of Rhizoma Chuanxiong, ice
Piece 1.
Embodiment 20 is used for the Chinese medicine composition (20) of Chinese medicine moxibustion
55 parts of Radix Angelicae Sinensis, 50 parts of safflower, 60 parts of Radix Salviae Miltiorrhizae, 15 parts of radix aucklandiae, 30 parts of rhizoma cyperi, 70 parts of motherwort, 25 parts of Rhizoma Chuanxiong, borneol
1。
Embodiment 21 is used for the Chinese medicine composition (21) of Chinese medicine moxibustion
55 parts of Radix Angelicae Sinensis, 50 parts of safflower, 60 parts of Radix Salviae Miltiorrhizae, 35 parts of radix aucklandiae, 30 parts of rhizoma cyperi, 70 parts of motherwort, 25 parts of Rhizoma Chuanxiong, borneol
1。
Embodiment 22 is used for the Chinese medicine composition (22) of Chinese medicine moxibustion
55 parts of Radix Angelicae Sinensis, 50 parts of safflower, 60 parts of Radix Salviae Miltiorrhizae, 35 parts of radix aucklandiae, 50 parts of rhizoma cyperi, 70 parts of motherwort, 25 parts of Rhizoma Chuanxiong, borneol
1。
Embodiment 23 is used for the Chinese medicine composition (23) of Chinese medicine moxibustion
55 parts of Radix Angelicae Sinensis, 50 parts of safflower, 60 parts of Radix Salviae Miltiorrhizae, 35 parts of radix aucklandiae, 50 parts of rhizoma cyperi, 90 parts of motherwort, 25 parts of Rhizoma Chuanxiong, borneol
1。
Embodiment 24 is used for the Chinese medicine composition (24) of Chinese medicine moxibustion
55 parts of Radix Angelicae Sinensis, 50 parts of safflower, 60 parts of Radix Salviae Miltiorrhizae, 35 parts of radix aucklandiae, 50 parts of rhizoma cyperi, 90 parts of motherwort, 45 parts of Rhizoma Chuanxiong, borneol
1。
Embodiment 25 is used for the Chinese medicine composition (25) of Chinese medicine moxibustion
55 parts of Radix Angelicae Sinensis, 50 parts of safflower, 60 parts of Radix Salviae Miltiorrhizae, 35 parts of radix aucklandiae, 50 parts of rhizoma cyperi, 90 parts of motherwort, 45 parts of Rhizoma Chuanxiong, borneol
3。
Embodiment 26 is used for the Chinese medicine composition (26) of Chinese medicine moxibustion
40 parts of Radix Angelicae Sinensis, 35 parts of safflower, 45 parts of Radix Salviae Miltiorrhizae, 20 parts of radix aucklandiae, 35 parts of rhizoma cyperi, 75 parts of motherwort, 30 parts of Rhizoma Chuanxiong, borneol
1。
Embodiment 27 is used for the Chinese medicine composition (27) of Chinese medicine moxibustion
50 parts of Radix Angelicae Sinensis, 45 parts of safflower, 55 parts of Radix Salviae Miltiorrhizae, 30 parts of radix aucklandiae, 45 parts of rhizoma cyperi, 85 parts of motherwort, 40 parts of Rhizoma Chuanxiong, borneol
2。
Embodiment 28 is used for the Chinese medicine composition (28) of Chinese medicine moxibustion
40 parts of Radix Angelicae Sinensis, 35 parts of safflower, 45 parts of Radix Salviae Miltiorrhizae, 20 parts of radix aucklandiae, 45 parts of rhizoma cyperi, 85 parts of motherwort, 40 parts of Rhizoma Chuanxiong, borneol
2。
Embodiment 29 is used for the Chinese medicine medicine salt of medicine salt moxibustion
Any Chinese medicine composition of Example 1-28, is added 700-900 parts of sea salt.
Preparation method of the embodiment 30 for the Chinese medicine composition of Chinese medicine moxibustion
(1) Chinese medicine material is weighed by any parts by weight of embodiment 1-28, takes 700-900 parts of sea salt；
(2) important composition is crushed, crosses 60-200 mesh, obtains Chinese medicinal powder；
(3) by sea salt mild fire frying, medicinal powder prepared by step 2, together frying is added in when light yellow complexion, and pack obtains Chinese medicine
Medicine salt.
31 moxibustion method of embodiment
The medicine salt prepared is cooled down spare, takes 100 grams of medicine salt to put into spun yarn cloth bags, as shown in Figure 1.When moxibustion, by yarn
Medicine salt, which is spread out, in cloth bag is flat on moxibustion cassette bottom portion skin.4-5 sections of moxa sticks are lighted and put moxibustion box into, moxibustion box is placed on medicine salt bag
Moxibustion.During moxa-moxibustion, moxibustion heat can penetrate progressively through medicine salt and enter cave area slowly and persistently play a role, the lasting warm of the patient feels
Infiltration.
Chinese medicine moxibustion composition (i.e. the Chinese medicine composition of embodiment 1-15) of the invention act on lumbosacral region governor vessel and
Two sides bladder meridian takes the big cave of the health cares such as shen shu, the gate of vitality, Yaoyangkuan(Du 3), has the function of element culturing fixed folder, kidney tonifying marrow facilitating, relaxing tendons and activating collaterals.
Governor vessel leads to spinal cord, and spinal nerve distribution all has with each internal organs in vivo and is closely connected, the back shu points of governor vessel both sides also with the five internal organs six
Internal organs is related, can improve whole body internal organs function by conditioning governor vessel and bladder meridian.Block suitable for back muscular strain, meridian qi and blood
Obstructed and whole body integrally improves.
Clinical trial of 32 present invention of embodiment for the traditional Chinese medicine composition for treating lumbar muscle strain of Chinese medicine moxibustion
1 clinical data
1.1 general information
120 lumbar muscle strain patients of research object selection hospital outpatient.Wherein women 55, male 65.It falls ill year
It is age 25-51 years old, average age 32 years old, the course of disease -2 years 2 months, 6 months average.Patient is randomly divided into four groups, every group of disease
Example general information no significant difference, is comparable (P > 0.05).
1.2 diagnostic criteria
The diagnostic criteria of lumbar muscle strain in the Standards for Diagnosis and Curative Effect of Chinese Medical Symptom promulgated referring to State Administration of Traditional Chinese Medicine.
Clinical symptoms: flank pain, when rest, mitigate, and aggravate when tired, and appropriate activity or while often changing position mitigate, and activity is exaggerated
Shi Jiachong, it is heavy when not yet get up in the morning, mitigate after light activity of getting up, slightly the pain increased long for work of bending over, and is hit sometimes with fist
Waist can make pain relief.Sign: waist can have extensive tenderness, and multidigit is in spinous process both sides musculus sacrospinalis position, crista iliaca rear portion or sacrum
It behind bone on low back muscle at point, touches that chronognosis psoas muscle elasticity is poor or psoas muscle occur stiff nonelastic, locally there is streak change；
Or psoas muscle wither it is soft, be in thin-cord type, tenderness is not acute, and waist scope of activities is without obvious obstacle.Check: how without exception x ray examination is, a small number of
Can there are osteoproliferation or deformity of spine.
1.3 cases are included in standard
Meet above-mentioned lumbar muscle strain diagnostic criteria, belongs to tcm syndrome classification kidney deficiency blood stasis type person, this treatment of voluntary participation
Method disables other treatment method during treatment.
1.4 exclusion criteria
(1) patients with lumbar disc herniation is excluded；(2) lumbar vertebrae other diseases are excluded, such as Spinal Diseases, spinal canal stenosis
And articulatio sacroiliaca and buttocks disease etc.；(3) it excludes to be associated with the destructions of bone persons such as bone tuberculosis, bone tumour；(4) exclude the gestational period or
Breast feeding women；(5) it excludes to merge severe primaries disease and the essences such as cardiovascular and cerebrovascular, liver, kidney, hemopoietic system, endocrine system
Refreshing patient.
2 research methods
2.1 treatment method
Treatment group: Chinese medicine medicine salt is prepared referring to the method for embodiment 1 and embodiment 30, is applied referring to the method for embodiment 31
Moxibustion, once a day.30 minutes every time.10 1 courses for the treatment of, totally 30 courses for the treatment of.
Compare one group: Chinese medicine composition is as follows: 50 parts of caulis piperis futokadsurae, 40 parts of the root of Chinese clematis, 45 parts of rhizoma cibotii, 50 parts of psoralea corylifolia, thoroughly
Bone grass 60 parts, 40 parts of lycopodium calvatum, 35 parts of Rhizoma Chuanxiong, 60 parts of ramulus mori, 50 parts of radix achyranthis bidentatae, 2 parts of borneol.It is prepared referring to the method for embodiment 30
Chinese medicine medicine salt, referring to the method moxibustion of embodiment 31, once a day.30 minutes every time.10 1 courses for the treatment of, totally 30 courses for the treatment of.
Compare two groups: Chinese medicine composition is as follows: 40 parts of the root of Chinese clematis, 50 parts of psoralea corylifolia, 60 parts of lopseed, is stretched 45 parts of rhizoma cibotii
Muscle grass 40 parts, 35 parts of Rhizoma Chuanxiong, 50 parts of radix achyranthis bidentatae, 2 parts of borneol.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, referring to embodiment
31 method moxibustion, once a day.30 minutes every time.10 1 courses for the treatment of, totally 30 courses for the treatment of.
Compare three groups: Chinese medicine composition is as follows: 20 parts of caulis piperis futokadsurae, 20 parts of the root of Chinese clematis, 20 parts of rhizoma cibotii, 20 parts of psoralea corylifolia, thoroughly
Bone grass 80 parts, 80 parts of lycopodium calvatum, 70 parts of Rhizoma Chuanxiong, 80 parts of ramulus mori, 80 parts of radix achyranthis bidentatae, 2 parts of borneol.It is prepared referring to the method for embodiment 30
Chinese medicine medicine salt, referring to the method moxibustion of embodiment 31, once a day.30 minutes every time.10 1 courses for the treatment of, totally 30 courses for the treatment of.
2.2 criterion of therapeutical effect
" the disease of tcm Standardization of diagnosis and curative effect " promulgated referring to State Administration of Traditional Chinese Medicine.
Cure: pain and tenderness disappear, and functional rehabilitation can work and work；Effective: pain obviously subtracts with tenderness
Gently, simultaneous phenomenon improves earlier above, and function is restored substantially, can work and work；Invalid: sings and symptoms are unchanged.Effectively
Rate=(curing number+effective number)/total number of persons.
3 treatment results
Test result such as following table.
Four groups of patient clinical curative effects compare after table 1 is treated
| Group | Number of cases | It cures (%) | Effective (%) | (%) in vain | Total effective rate (%) |
| Treatment group | 36 | 21(58.3) | 11(30.6) | 4(11.1) | 32(88.9) |
| Compare one group | 28 | 7(25.0)* | 9(32.1) | 12(42.9) | 16(57.1)* |
| Compare two groups | 28 | 8(28.6)* | 11(39.3) | 9(32.1) | 19(67.9)* |
| Compare three groups | 28 | 7(25.0)* | 17(60.7) | 4(14.3) | 24(85.7) |
Note: * indicates P < 0.05 compared with treatment group.
By the treatment and follow-up of three courses for the treatment of, treatment group cures 21 people, effective 11 people as the result is shown, and invalid 4 people always has
Efficiency 88.9%.Compared with one group of control, two groups of control, treatment group's total effective rate and cure rate are significantly better than control for treatment group
One group and two groups of control, P < 0.05, difference have statistical significance.Compared with three groups of control, treatment group's cure rate is aobvious for treatment group
It writes better than three groups of control, P < 0.05, difference has statistical significance.The above results show treatment group's curative effect better than control group.
Apparent adverse events all do not occur during above-mentioned four groups of patients treatment.Do not occur apparent hepatic and renal function damage
Evil, serious disease in the blood system and cardiovascular and cerebrovascular accident.Illustrate the treatment of the traditional chinese medicine composition of the invention to patient without bright
Aobvious adverse effect.
Clinical trial of 33 present invention of embodiment for the traditional Chinese medicine composition for treating dysmenorrhea of Chinese medicine moxibustion
1 clinical data
1.1 general information
Research object selects 100 dysmenorrhea patients to clarify a diagnosis of hospital outpatient, is randomly divided into 4 groups, treatment group 31,
It is age 17-27 years old, 20.6 years old average, it is the course of disease 4 months to 5 years, 3.18 years average；One group 23 are compareed, the age 17-31 years old, is put down
It is equal 23.3 years old, the course of disease 4 months to 6 years, 3.31 years average；Two groups 23 are compareed, the age 16-27 years old, 19.5 years old average, the course of disease 3
It is a month to 4 years, 3.51 average；Three groups 23 are compareed, the age 18-29 years old, averagely 19.8 years old are the course of disease 4 months to 4 years, average
3.11 year.Four groups of patient's general information (including age, the course of disease, state of an illness) through statistical analysis, no significant difference (P >
0.05) it, is comparable.
1.2 diagnostic criteria
Referring to new Chinese medicine guideline of clinical investigations
(1) tcm diagnosis standard: women is all in menstrual period or through based on the periodical hypogastralgia of front and back appearance in (1 week or more)
Disease, with other discomforts, so that influencing life and worker.Chinese medical discrimination belongs to syndrome of blood stasis, premenstruum (premenstrua) lower abdominal distention pain, after menstruation
Phase amount is few, and menses are dark, and tongue fur is white or dark violet, small and wiry pulse or heavy tight；
(2) Western medicine diagnostic criteria: through gynecologial examination, genitals without significant organic pathology, be mainly in 2 after menarche~
3 years maidens, or the young woman that do not give birth to；
1.3 cases are included in standard
Age 17-30 years old unmarried female meets the diagnostic criteria of doctor trained in Western medicine primary dysmenorrhea, meets the diagnosis of Chinese medicine dysmenorrhea
Standard, menstrual cycle in (28 ± 7) d, voluntarily receive treatment, observation.
1.4 exclusion criteria
Through B ultrasound and gynecologial examination, it was demonstrated that due to diseases such as endometriosis, pelvic inflammatory disease, adenomyosis or other
Acquired dysmenorrhea caused by factor；Menstrual cycle irregular person；Other related treatments are received, the effect of this research may be influenced
Index observing person；It is associated with the primary disease of the serious threat to life such as cardiovascular and cerebrovascular, liver, kidney and hemopoietic system, and spirit
Patient etc..
2 research methods
2.1 treatment method
Treatment group: Chinese medicine medicine salt is prepared referring to the method for embodiment 16 and embodiment 30, is applied referring to the method for embodiment 31
Moxibustion, 7 days before menstrual onset start to treat, and 2 times a day, 10 days as a treatment course treat 2 menstrual cycles.
Compare one group: Chinese medicine composition is as follows: 45 parts of Radix Angelicae Sinensis, 40 parts of safflower, 50 parts of Radix Salviae Miltiorrhizae, 25 parts of radix aucklandiae, motherwort 80
Part, 35 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, referring to the method moxibustion of embodiment 31.Menstruation
It rises first 7 days and starts to treat, 2 times a day, 10 days as a treatment course treat 2 menstrual cycles.
Compare two groups: Chinese medicine composition is as follows: 45 parts of Radix Angelicae Sinensis, 40 parts of safflower, 50 parts of Radix Salviae Miltiorrhizae, 25 parts of radix aucklandiae, 40 parts of rhizoma cyperi,
35 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, referring to the method moxibustion of embodiment 31.Menstrual onset
Start to treat within first 7 days, 2 times a day, 10 days as a treatment course treat 2 menstrual cycles.
Compare three groups: Chinese medicine composition is as follows: 20 parts of Radix Angelicae Sinensis, 70 parts of safflower, 70 parts of Radix Salviae Miltiorrhizae, 60 parts of radix aucklandiae, 70 parts of rhizoma cyperi,
50 parts of motherwort, 70 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, is applied referring to the method for embodiment 31
Moxibustion.Start to treat within 7 days before menstrual onset, 2 times a day, 10 days as a treatment course treat 2 menstrual cycles.
2.2 symptom integral standards
Symptom integral standard: menstrual period and its front and back underbelly pain 5 are divided on (basis point), and unbearably 1 point of abdominal pain, abdominal pain obvious 0.5
Point, dripping cold sweat 1 divides, and peripheral coldness 1 divides, and feels restless 1 point, suffers a shock 1 point, Mian Se Koushi is white, need to lie up 1 point, influence work
Make 1 point of study, divided with general analgesic measure not alleviation person 1, divided with general analgesic measure alleviation person 0.5, aches 0.5 with waist
Point, divide with nausea and vomiting 0.5, divides with rectal tenesmus 0.5,0.5 point (every increase by 1 day plus 0.5 point) of the pain within 1 day.
2.3 criterion of therapeutical effect
It is formulated referring to " new Chinese medicine guideline of clinical investigations ".Cure: post treatment integral is restored to 0 point, abdominal pain and its
He disappears at symptom, and stopping 3 periods for the treatment of do not recur；It is effective: after treatment symptom integral be down to before treatment 1/2 hereinafter, abdominal pain
Substantially reduced, remaining symptom improves, and refuses to obey that anodyne can also adhere to work；It is effective: before symptom integral is down to treatment after treatment
1/2~3/4 hereinafter, abdominal pain mitigates, remaining symptom improves, and work can be adhered to by taking anodyne；Invalid: abdominal pain and other symptoms are without bright
It is aobvious to change.Total effective rate=(curing number+effective number+significant figure)/total number of persons.
2.4 statistical procedures
Statistical method is for statistical analysis using spss19.0, is examined using t, and P < 0.05 is that difference is anticipated with statistics
Justice.
3 treatment results
Test result such as following table.
Four groups of patient clinical curative effects compare after table 2 is treated
| Group | Number of cases | It cures (%) | Effective (%) | Effectively (%) | (%) in vain | Total effective rate (%) |
| Treatment group | 31 | 21(67.7) | 5(16.1) | 3(9.7) | 2(6.5) | 29(93.5) |
| Compare one group | 23 | 5(21.7)* | 7(30.4) | 6(26.1) | 5(21.7) | 18(78.3)* |
| Compare two groups | 23 | 6(26.1)* | 8(34.8) | 4(17.4) | 5(21.7) | 18(78.3)* |
| Compare three groups | 23 | 6(26.1)* | 13(56.5) | 2(8.7) | 2(8.7) | 21(91.3) |
Note: * indicates P < 0.05 compared with treatment group.
It can see from the result of table 2, after 2 menstrual cycles treat, treatment group 21 people of healing, effective 5 people, effectively
3 people, invalid 2 people, cure rate 67.7%, total effective rate 93.5%.Treatment group controls compared with one group of control, two groups of control
Treatment group cure rate and total effective rate are significantly better than two groups one group of control, control (P < 0.05), and difference has statistical significance.It controls
For treatment group compared with three groups of control, treatment group's cure rate is significantly better than three groups (P < 0.05) of control, and difference has statistical significance.On
It states the result shows that treatment group's curative effect is better than control group.
Clinical trial of 34 present invention of embodiment for the traditional Chinese medicine composition for treating irregular menstruation of Chinese medicine moxibustion
1 clinical data
Select 110 irregular menstruation patients as research object, through gynecologial examination and vaginal fluid routine inspection,
Meet the diagnostic criteria of irregular menstruation in " guideline of clinical investigations of new Chinese medicine ".Exclusion criteria: (1) adenomyosis,
Irregular menstruation caused by the reproductive organs matter venereal disease such as fibroid, pituitary tumor becomes；(2) cardiovascular, Liver and kidney function serious hindrance
Person；(3) dysnoesia or psychiatric system class Disease；(4) allergic constitution or a variety of drug allergy persons, patient show as menstruation
In advance, delayed menstrual cycle, menstruation successively irregularly, menstrual flow it is too little or too much.All patients are randomly divided into four groups, every group of patient one
As data (including age, the course of disease, state of an illness) be comparable through statistical analysis, no significant difference (P > 0.05).
2 research methods
2.1 treatment method
Treatment group: Chinese medicine medicine salt is prepared referring to the method for embodiment 16 and embodiment 30, is applied referring to the method for embodiment 31
Moxibustion.Start to treat within the 5th day after the menstrual cycle, one time a day, continuous 10 times are 1 course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
Compare one group: Chinese medicine composition is as follows: 45 parts of Radix Angelicae Sinensis, 40 parts of safflower, 50 parts of Radix Salviae Miltiorrhizae, 25 parts of radix aucklandiae, motherwort 80
Part, 35 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, referring to the method moxibustion of embodiment 31.Yu Yue
Start to treat within the 5th day after the period, one time a day, continuous 10 times are 1 course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
Compare two groups: Chinese medicine composition is as follows: 45 parts of Radix Angelicae Sinensis, 40 parts of safflower, 50 parts of Radix Salviae Miltiorrhizae, 25 parts of radix aucklandiae, 40 parts of rhizoma cyperi,
35 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, referring to the method moxibustion of embodiment 31.In menstruation week
Start to treat within the 5th day after phase, one time a day, continuous 10 times are 1 course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
Compare three groups: Chinese medicine composition is as follows: 20 parts of Radix Angelicae Sinensis, 70 parts of safflower, 70 parts of Radix Salviae Miltiorrhizae, 60 parts of radix aucklandiae, 70 parts of rhizoma cyperi,
50 parts of motherwort, 70 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, is applied referring to the method for embodiment 31
Moxibustion.Start to treat within the 5th day after the menstrual cycle, one time a day, continuous 10 times are 1 course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
2.2 symptom score standards
Respectively at before and after treatment to patient's progress symptom score.Standards of grading: according to " clinical research of new Chinese medicine is instructed
Principle " Syndrome Scale quantization table scores, aches including waist sacrum, lower abdominal distention pain, swollen breasts, spiritlessness and weakness, few gas
The symptoms such as lazy speech, aversion to cold and cold limbs, less serious case are 1 point, and middle person is 2 points, and severe one is 3 points.
2.3 criterion of therapeutical effect
Recovery from illness: stopping in patient's colporrhagia 3-5 days after treatment, and menstrual cycle, amount, menstrual period are restored normal, clinical condition
Shape disappears substantially, and integral reduces >=95%；It is effective: stop in patient's colporrhagia 5-7 days after treatment, menorrhalgia person measured compared with
Reduction<100mL before treating, menstrual period restored within 7 days, and clinical symptoms disappear or mitigate substantially, and integral reduces>=70%；Have
Effect: stopping in patient's colporrhagia 7-10 days after treatment, and menstrual cycle, menstrual period make moderate progress before relatively treating through amount, and integral is reduced
>=30%；It is invalid: stop within patient's colporrhagia 10 days or more after treatment, the menstrual cycle, through amount, menstrual period without improvement, integral reduces <
30%.Total effective rate=(curing number+effective number+significant figure)/total number of persons.
2.4 statistical procedures
Statistical method is for statistical analysis using spss19.0, is examined using t, and P < 0.05 is that difference is anticipated with statistics
Justice.
3 treatment results
Test result such as following table.
Four groups of patient clinical curative effects compare after table 3 is treated
| Group | Number of cases | It cures (%) | Effective (%) | Effectively (%) | (%) in vain | Total effective rate (%) |
| Treatment group | 35 | 23(65.7) | 7(20.0) | 3(8.6) | 2(5.7) | 33(94.3) |
| Compare one group | 25 | 6(24.0)* | 8(32.0) | 6(24.0) | 5(20.0) | 20(80.0)* |
| Compare two groups | 25 | 7(28.0)* | 9(36.0) | 5(20.0) | 4(16.0) | 21(84.0)* |
| Compare three groups | 25 | 8(32.0)* | 13(56.5) | 2(8.0) | 2(8.0) | 23(92.0) |
Note: * indicates P < 0.05 compared with treatment group.
It can see from the result of table 3, after 2 course of therapy, treatment group 23 people of healing, effective 7 people, effective 3 people,
Invalid 2 people, cure rate 65.7%, total effective rate 94.3%.Treatment group is compared with one group of control, two groups of control, treatment group
Cure rate and total effective rate be significantly better than control one group, control two groups (P < 0.05), difference have statistical significance.Treatment
For group compared with three groups of control, treatment group's cure rate is significantly better than three groups (P < 0.05) of control, and difference has statistical significance.It is above-mentioned
The result shows that treatment group's curative effect is better than control group.
Clinical trial of 35 present invention of embodiment for the traditional Chinese medicine composition for treating chronic pelvic inflammatory disease of Chinese medicine moxibustion
1 clinical data
1.1 general information
120 outpatients of gynecology are selected, chronic pelvic inflammation diagnostic criteria is met, according to table of random number, by patient point
For treatment group, one group of control, two groups of control, three groups of control.Four groups of patient's general information (including age, the course of disease, state of an illness) are through uniting
Credit analysis is counted, no significant difference (P > 0.05) is comparable.
1.2 diagnostic criteria
Western medicine diagnostic criteria: (1) there is acute pelvitis of pelvic cavity history；(2) lower abdomen pendant rises, and pain and waist sacrum are ached, often in tired, property
It hands over and menstruation front and back is aggravated；(3) vaginal discharge；(4) fundus of uterus tenderness and uterus side or bilateral touch streak packet
Block；(5) ultrasonic examination can be visited and abnormal echo or irregular dark space or uterus rectum is recessed hydrops；(6) except pelvic congestion or
The diseases such as broad ligament internal jugular vein varicose.
Standards of Chinese Medical Syndrome Differentiation: inferior belly gas pain or shouting pain, sore spot are fixed, and waist sacrum is gone up painful, profuse leukorrhea, and color Huang taste is smelly.Minor symptom
Show themselves in that spiritlessness and weakness, low-heat rises and falls, and uncomfortable in chest indigestion and loss of appetite, menostaxis by hyper-menorrhea or companion, and bellyache in menstrual period aggravates, and urine is yellow, greatly
Just dry or half congealed and not well.Tongue vein is mostly that petechia or ecchymosis are seen in red or kermesinus, tongue side.
1.3 are included in standard
(1) meet chronic pelvic inflammation diagnostic criteria；
(2) age 19-50 years old non-menopausal women；
(3) signed informed consent form.
1.4 exclusion criteria
(1) age is in under-18s, 51 years old or more person；
(2) belong to endometriosis person；
(3) merge the serious diseases patients such as the heart, liver, kidney and hemopoietic system, mental patient；
(4) to drug allergy person.
2 research methods
2.1 treatment method
Treatment group: Chinese medicine medicine salt is prepared referring to the method for embodiment 16 and embodiment 30, is applied referring to the method for embodiment 31
Moxibustion.Start to treat after clean period, one time a day, menstrual period stop moxibustion, continuously treat 2 months evaluation curative effects.
Compare one group: Chinese medicine composition is as follows: 45 parts of Radix Angelicae Sinensis, 40 parts of safflower, 50 parts of Radix Salviae Miltiorrhizae, 25 parts of radix aucklandiae, motherwort 80
Part, 35 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, referring to the method moxibustion of embodiment 31.Yu Yue
Start to treat after clean, one time a day, menstrual period stop moxibustion, continuously treat 2 months evaluation curative effects.
Compare two groups: Chinese medicine composition is as follows: 45 parts of Radix Angelicae Sinensis, 40 parts of safflower, 50 parts of Radix Salviae Miltiorrhizae, 25 parts of radix aucklandiae, rhizoma cyperi 40
Part, 35 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, referring to the method moxibustion of embodiment 31.Yu Yue
Start to treat after clean, one time a day, menstrual period stop moxibustion, continuously treat 2 months evaluation curative effects.
Compare three groups: Chinese medicine composition is as follows: 20 parts of Radix Angelicae Sinensis, 70 parts of safflower, 70 parts of Radix Salviae Miltiorrhizae, 60 parts of radix aucklandiae, 70 parts of rhizoma cyperi,
50 parts of motherwort, 70 parts of Rhizoma Chuanxiong, borneol 2.Chinese medicine medicine salt is prepared referring to the method for embodiment 30, is applied referring to the method for embodiment 31
Moxibustion.Start to treat after clean period, one time a day, menstrual period stop moxibustion, continuously treat 2 months evaluation curative effects.
2.2 criterion of therapeutical effect
Cure: clinical symptoms, sign disappear, and gynaecology and ultrasonic examination report are shown no obvious abnormalities；
Effective: clinical symptoms, sign and gynaecology and ultrasound have mitigation；
Invalid: clinical symptoms, sign and gynaecology and ultrasonic examination are not improved.
3 treatment results
Test result such as following table.
Four groups of patient clinical curative effects compare after table 4 is treated
| Group | Number of cases | It cures (%) | Effectively (%) | (%) in vain | Total effective rate (%) |
| Treatment group | 30 | 23(76.7) | 3(10.0) | 4(13.3) | 26(86.7) |
| Compare one group | 30 | 9(30.0)* | 14(46.7) | 7(23.3) | 23(76.7)* |
| Compare two groups | 30 | 9(30.0)* | 13(43.3) | 8(26.7) | 22(73.3)* |
| Compare three groups | 30 | 12(40)* | 13(43.3) | 5(10.0) | 25(83.3) |
Note: * indicates P < 0.05 compared with treatment group.
It can see from the result of table 3, after treatment in 2 months, treatment group cures 23 people, effective 3 people, and invalid 4 people controls
More rate is 76.7%, total effective rate 76.7.Treatment group is compared with one group of control, two groups of control, the cure rate for the treatment of group and total
Effective percentage is significantly better than two groups one group of control, control (P < 0.05), and difference has statistical significance.Treatment group with compare three groups
Compare, treatment group's cure rate is significantly better than three groups (P < 0.05) of control, and difference has statistical significance.The above results show to treat
Group curative effect is better than control group.
The above is only a preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art
Member, under the premise of not departing from the method for the present invention, can also make several improvement and supplement, these are improved and supplement also should be regarded as
Protection scope of the present invention.
Claims (6)
1. application of the Chinese medicine medicine salt in the drug of the medicine salt moxibustion of preparation treatment lumbar muscle strain；The Chinese medicine medicine salt include sea salt and
Chinese medicine composition；The Chinese medicine composition is made of the bulk pharmaceutical chemicals of following parts by weight: 40-60 parts of caulis piperis futokadsurae, root of Chinese clematis 30-50
Part, 35-55 parts of rhizoma cibotii, 40-60 parts of psoralea corylifolia, 50-70 parts of lopseed, 30-50 parts of lycopodium calvatum, 25-45 parts of Rhizoma Chuanxiong, ramulus mori 50-
70 parts, 40-60 parts of radix achyranthis bidentatae, 1-3 parts of borneol；The parts by weight of the sea salt are 700-900 parts.
2. application according to claim 1, which is characterized in that the drug the preparation method is as follows:
(1) raw material is weighed according to the proportion；
(2) Chinese medicine composition is crushed, is sieved with 100 mesh sieve, obtain medicinal powder；
(3) sea salt mild fire frying is taken, medicinal powder prepared by step 2, together frying is added in when light yellow complexion.
3. application according to claim 1, which is characterized in that the Chinese medicine composition by following parts by weight bulk pharmaceutical chemicals system
At: 45-55 parts of caulis piperis futokadsurae, 35-45 parts of the root of Chinese clematis, 40-50 parts of rhizoma cibotii, 45-55 parts of psoralea corylifolia, 55-65 parts of lopseed, lycopodium calvatum
35-45 parts, 30-40 parts of Rhizoma Chuanxiong, 55-65 parts of ramulus mori, 45-55 parts of radix achyranthis bidentatae, 1-2 parts of borneol.
4. application according to claim 1, which is characterized in that the Chinese medicine composition by following parts by weight bulk pharmaceutical chemicals system
At: 50 parts of caulis piperis futokadsurae, 40 parts of the root of Chinese clematis, 45 parts of rhizoma cibotii, 50 parts of psoralea corylifolia, 60 parts of lopseed, 40 parts of lycopodium calvatum, 35 parts of Rhizoma Chuanxiong,
60 parts of ramulus mori, 50 parts of radix achyranthis bidentatae, 2 parts of borneol.
5. application according to claim 1, which is characterized in that the Chinese medicine composition by following parts by weight bulk pharmaceutical chemicals system
At: 40 parts of caulis piperis futokadsurae, 30 parts of the root of Chinese clematis, 35 parts of rhizoma cibotii, 40 parts of psoralea corylifolia, 50 parts of lopseed, 30 parts of lycopodium calvatum, 25 parts of Rhizoma Chuanxiong,
50 parts of ramulus mori, 40 parts of radix achyranthis bidentatae, 1 part of borneol.
6. application according to claim 1, which is characterized in that the Chinese medicine composition by following parts by weight bulk pharmaceutical chemicals system
At: 60 parts of caulis piperis futokadsurae, 50 parts of the root of Chinese clematis, 55 parts of rhizoma cibotii, 60 parts of psoralea corylifolia, 70 parts of lopseed, 50 parts of lycopodium calvatum, 45 parts of Rhizoma Chuanxiong,
70 parts of ramulus mori, 60 parts of radix achyranthis bidentatae, 3 parts of borneol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610494727.9A CN105943644B (en) | 2016-06-29 | 2016-06-29 | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610494727.9A CN105943644B (en) | 2016-06-29 | 2016-06-29 | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105943644A CN105943644A (en) | 2016-09-21 |
| CN105943644B true CN105943644B (en) | 2019-11-22 |
Family
ID=56902966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610494727.9A Active CN105943644B (en) | 2016-06-29 | 2016-06-29 | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105943644B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111617181A (en) * | 2020-06-04 | 2020-09-04 | 雷霞 | Medicine for treating rheumatic lumbocrural pain and traumatic injury |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015641A (en) * | 2007-02-16 | 2007-08-15 | 王卫平 | Moxibustion medicine for treating pain of lumbus, leg, neck and shoulder |
| CN102430011A (en) * | 2011-12-12 | 2012-05-02 | 上海市针灸经络研究所 | Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
| CN103860667A (en) * | 2014-02-28 | 2014-06-18 | 青岛恒波仪器有限公司 | Traditional Chinese medicine composition for treating lumbar muscle strain and preparation method thereof |
-
2016
- 2016-06-29 CN CN201610494727.9A patent/CN105943644B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015641A (en) * | 2007-02-16 | 2007-08-15 | 王卫平 | Moxibustion medicine for treating pain of lumbus, leg, neck and shoulder |
| CN102430011A (en) * | 2011-12-12 | 2012-05-02 | 上海市针灸经络研究所 | Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
| CN103860667A (en) * | 2014-02-28 | 2014-06-18 | 青岛恒波仪器有限公司 | Traditional Chinese medicine composition for treating lumbar muscle strain and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 隔药饼灸结合刮痧治疗肾虚型腰肌劳损的临床研究;叶佩青;《中国优秀硕士学位论文全文数据库医药卫生科技辑》;20150115;第16页"治疗组 隔药饼灸"、第24页第21-25行 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105943644A (en) | 2016-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
| CN101961443B (en) | Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN105435297A (en) | Traditional Chinese medicine sanitary article for treating women dysmenorrheal, cold in uterus and vaginal eczema | |
| CN104784673B (en) | A kind of Chinese traditional medicine navel for infantile diarrhea pastes | |
| CN103585378A (en) | A Chinese medicinal composition for treating female infertility, and its preparation method | |
| CN106620623A (en) | Hot-dressing external traditional Chinese medicinal composition and five-element moxibustion therapy packet containing composition | |
| CN104491675B (en) | Huoxue Huayu Decoction | |
| CN106039245A (en) | External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof | |
| CN102895447A (en) | Chinese medicinal ointment for treating orthopaedic diseases and preparation method thereof | |
| CN107550982A (en) | A kind of Chinese medicine composition and the moxa-moxibustion medicine for treating disadvantage disease | |
| CN103720851A (en) | Traditional Chinese medicinal decoction for treating osteoproliferation | |
| CN105943644B (en) | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain | |
| CN106389557B (en) | A kind of Chinese medicine composition and its preparation method and application for Chinese medicine moxibustion | |
| CN103463261B (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation | |
| CN102198202B (en) | Pills for treating gout | |
| CN102091169B (en) | Traditional Chinese medicine capsule capable of tonifying liver and kidney, promoting blood circulation by removing blood stasis, dispelling wind, cold and dampness | |
| CN103520450A (en) | Traditional Chinese medicine treating postpartum rheumatism | |
| CN103585609A (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
| CN106215051A (en) | A kind of Chinese and Western compound medicine treating peripheral nerve injury and preparation method | |
| CN1142389A (en) | Chinese medical composition for hernia | |
| CN102133380B (en) | Medicament for treating cervical spondylosis | |
| CN104857440A (en) | Traditional Chinese medicine for treating kidney deficiency and blood stasis type medium and advanced osteonecrosis of femoral head and preparation method of the traditional Chinese medicine | |
| CN100446808C (en) | Medicine for treating cold after delivery | |
| CN109091570A (en) | A kind of Chinese medicine for treating chorionitis | |
| CN101007162A (en) | Medicine bag containing traditional Chinese medicine for physiotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |